Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Massive spending bill passes final vote in Congress with Medicaid cuts intact
The 940-page document passed the House of Representatives in a 218 to 214 vote, and now heads to President Donald Trump’s desk. It contains a 20% cut to federal Medicaid funding, something Trump said he opposes.
Radiation in the cath lab: Tracking state-level regulations for cardiologists
Researchers hope these policies can be standardized in the future to help avoid confusion and improve clinician safety.
Doc groups say payer promises not enough to address care denials
MGMA and others who are part of the “Regulatory Relief Coalition” are urging Congress to continue pushing forward with the Improving Seniors’ Timely Access to Care Act.
Russian researcher strategizes on collaboration with China over healthcare AI
Have you ever wondered what China and Russia would talk about if they were to discuss AI in healthcare? It turns out they do just that—and a newly published academic paper straight out of the Russian Federation offers a glimpse into the dialogue.
10-second brain MRI scans possible with newly FDA-cleared deep learning reconstruction software
The artificial intelligence-enabled software offers accelerated acquisition times, improved image resolution and one-click workflows for technologists.

Embolization is a safe, cost-effective alternative to a hysterectomy, but patients are not using the IR service in some geographies.

The Food and Drug Administration approval comes amid growing interest in remote-scan technology following the COVID pandemic.

Fevers of unknown origin account for around 2% of hospitalizations and can present significant diagnostic challenges for providers.

Accrediting body IAC said revisions help imaging facilities ensure the safe delivery of MRIs, including when key personnel are located off-site.

Acoramidis, a selective transthyretin stabilizer being sold under the brand name Attruby, is now the second ATTR-CM medication to gain FDA approval.

According to an analysis from the Commonwealth Fund, millions of patients are skipping necessary care and struggling to pay mounting medical debt.

Medtronic designed its new Smart MDI system to provide real-time insights to users on multiple daily injection therapy.

An influential industry group, AdvaMed, really likes President-Elect Trump’s choice of Dr. Oz for CMS administrator.